Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Current Trends in Antibody Drug Conjugates

Sanghamitra Bhattacharjee's Biography

Sanghamitra Bhattacharjee, Senior Scientist, Theramyt Novobiologics Pvt. Ltd

Mrs Sanghamitra Bhattacharjee is presently working as a Senior Scientist at Theramyt Novobiologics. She has worked as a Senior Scientist at Bio-research Dept., Corporate R&D, Sami Labs and as a Scientist at Connexios Life Sciences Pvt. Ltd. She has nine years of industrial expertise. Her areas of expertise include bio-assay development and screening of new molecular entities, phytochemicals and biologicals targeted against metabolic syndromes like diabetes and cancer. She is skilled in mammalian cell biology, molecular biology and mechanistic studies to decipher mode of action of NME(s).She graduated from Berhampur University, Orissa with B.Pharm followed by M.Tech in Biotechnology from VIT, Vellore and worked on “Purification of Acetylcholinesterase by Affinity Chromatography and Immunochemical studies” under guidance of Dr. Anna Oommen, HOD, Neuro Chemistry Lab, CMC&H, Vellore. her publications from Connexios Life Sciences Pvt. Ltd. are as follows,
• BMC Pharmacology and Toxicology 2013, 14:28
‘Treatment with CNX-011-67, a novel GPR40 agonist, delays onset and progression of diabetes and improves beta cell preservation and function in male ZDF rats’
• BMC Cell Biology 2013, 14:31
Chronic glucolipotoxic conditions in pancreatic islets impair insulin secretion due to dysregulated calcium dynamics, glucose responsiveness and mitochondrial activity
• BMC Pharmacology and Toxicology 2014, 15:19
CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients
• BMC Cell Biology 2014, 15:24
Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic ß-cells health and function

Sanghamitra  Bhattacharjee Image

Bioanalytical & Pre-Clinical Development Strategies for ADCs

Tuesday, 3 March 2015 at 15:30

Add to Calendar ▼2015-03-03 15:30:002015-03-03 16:30:00Europe/LondonBioanalytical and Pre-Clinical Development Strategies for ADCsCurrent Trends in Antibody Drug Conjugates in Bangalore, IndiaBangalore,

In this talk, development of trastuzumab-emtansine will be discussed as a case study. Further, it will throw light on Product Development and Pre-Clinical Strategies for ADCs.

Add to Calendar ▼2015-03-02 00:00:002015-03-03 00:00:00Europe/LondonCurrent Trends in Antibody Drug ConjugatesCurrent Trends in Antibody Drug Conjugates in Bangalore, IndiaBangalore,